Home > Insider Trading > Filing (0001333493-19-000101)

Filing Details

Accession Number:: 0001333493-19-000101
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2019-07-31 20:16:28
Reporting Period:: 2019-07-30

Accepted Time:: 2019-07-31 20:16:28
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1333493	Ehealth Inc.	EHTH	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1327337	N Scott Flanders	C/O Ehealth, Inc. 2625 Augustine Drive, Second Floor Santa Clara CA 95054	Chief Executive Officer	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2019-07-30	92,016	$12.04	822,188	No	4	M	Direct
Common Stock	Acquisiton	2019-07-30	7,500	$12.20	829,688	No	4	M	Direct
Common Stock	Disposition	2019-07-30	11,094	$101.64	818,594	No	4	S	Direct
Common Stock	Disposition	2019-07-30	10,659	$102.71	807,935	No	4	S	Direct
Common Stock	Disposition	2019-07-30	13,484	$103.81	794,451	No	4	S	Direct
Common Stock	Disposition	2019-07-30	39,221	$104.81	755,230	No	4	S	Direct
Common Stock	Disposition	2019-07-30	23,758	$105.53	731,472	No	4	S	Direct
Common Stock	Disposition	2019-07-30	1,300	$106.38	730,172	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Performance Stock Option	Disposition	2019-07-30	92,016	$12.04	92,016	$12.04
Common Stock	Employee Stock Option (right to buy)	Disposition	2019-07-30	7,500	$12.20	7,500	$12.20

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0	2018-03-15	2024-03-31	No	4	M	Direct
0		2020-06-15	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	3,000	Indirect	UTMA Accounts For Grandchildren

Footnotes

The transactions reported on this date were effected pursuant to a Rule 10b5-1 trading plan. The transactions consist of (i) the cashless sale of an option to purchase 92,016 shares that were originally issued in lieu of a performance-based cash bonus opportunity for 2017 and (ii) the cashless sale of an option to purchase 7,500 shares that was scheduled to expire on 6/15/2020.
Total amount of shares beneficially owned includes shares deferred upon vesting of certain restricted stock units. The deferred shares will be settled in accordance with the terms of the deferral election.
The price reported in Table I, Column 4 for sales on 7/30/2019 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $101.14 to $102.13, inclusive. The reporting person undertakes to provide to eHealth, Inc., any security holder of eHealth Inc., or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (3) to (8) of this Form 4.
The price reported in Table I, Column 4 for sales on 7/30/2019 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $102.16 to $103.15, inclusive.
The price reported in Table I, Column 4 for sales on 7/30/2019 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $103.20 to $104.18, inclusive.
The price reported in Table I, Column 4 for sales on 7/30/2019 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $104.21 to $105.20, inclusive.
The price reported in Table I, Column 4 for sales on 7/30/2019 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $105.21 to $106.20, inclusive.
The price reported in Table I, Column 4 for sales on 7/30/2019 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $106.21 to $106.59, inclusive.
The performance-based stock option was granted in lieu of a performance-based cash bonus opportunity for 2017. The performance based stock option vested as to 92,016 shares upon compensation committee's certification of the achievement of the revenue and adjusted EBITDA goals that would have applied to Mr. Flanders' cash bonus.
The option vested as to 100% of the shares approximately one year following the grant date. The option is scheduled to expire on 6/15/20.